Current | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
Celera to Webcast Presentation at Seventh Annual JMP Securities Research Conference
FOR IMMEDIATE RELEASE
Alameda, CA - May 14, 2008
Celera (NYSE:CRA), an Applera Corporation business, today announced that it will webcast its presentation at the Seventh Annual JMP Securities Research Conference on Wednesday, May 21, 2008. The live webcast is scheduled to begin at 11:00 a.m. PT (2:00 p.m. ET). The conference format is for Joel Jung, Vice President, Finance, at Celera, to provide a brief opening statement with an overview of the business, followed by a question and answer session with investors and the firm’s financial analysts.
Interested parties may access the live webcast and replay by visiting the Investors & Media section of either the Celera web site at www.celera.com or the Applera website at www.applera.com. It is suggested that interested parties access the webcast 15 minutes before the start of the live broadcast. The webcast replay will be archived on the Presentations page of the Investors & Media section of each website.
About Applera Corporation and Celer
Applera Corporation consists of two operating groups. Celera is a diagnostics business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and optimize patient management. Celera also commercializes a wide range of molecular diagnostic products through its strategic alliance with Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Applied Biosystems serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems’ products also serve the needs of some markets outside of life science research, which we refer to as “applied markets,” such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, such as testing required for food and pharmaceutical manufacturing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of approximately $2.1 billion during fiscal 2007. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Celera is available at http://www.celera.com.
Celera Contact
David Speechly, Ph.D.
tel.: 510.749.1853
email: david.speechly@celera.com
Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.